Gelteq Limited Ordinary Shares (GELS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $0.56 (-3.74%), Market cap $0.00B, 52-week low–high $0.39 ~ $2.95.
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Financial statements, price targets, institutional (13F) holdings and related news for Gelteq Limited Ordinary Shares are updated in real time on BlackAll Trade.
Gelteq Limited Ordinary Shares trades at $0.56 (-3.74%). Real-time quotes and charts are available on BlackAll Trade.
Gelteq Limited Ordinary Shares has a market cap of about $0.00B.
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescr